Alterna Therapeutics
2015
FOUNDED
PRIVATE
STATUS
Accelerator/Inc
LATEST DEAL TYPE
2
INVESTORS
Description
Developer of therapeutics intended to treat diabetes and obesity. The company's therapeutics target fat tissues that are known to limit inflammation and SHIP enzyme for the treatment of obesity, enabling patients to control obesity without any side effects.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Other Healthcare Services
Primary Office
- 201 West Main Street
- Suite 300, PMB 317
- Durham, NC 27701
- United States
+1 (919) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Alterna Therapeutics’s full profile, request a free trial.
Alterna Therapeutics Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Accelerator/Incubator | 02-Mar-2016 | Completed | Startup | |||
| 1. Seed Round | 15-Nov-2015 | Completed | Startup |
Alterna Therapeutics Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| JLABS | Accelerator/Incubator | Minority | 000 0000 | 000000 0 | ||
| Golden Pine Ventures | Venture Capital | Minority | 000 0000 | 000000 0 |